Crispr Therapeutics shares owned by Twin Lakes Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Twin Lakes Capital Management
from 13F filings
Historical chart of Twin Lakes Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Twin Lakes Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Twin Lakes Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $47k | 682 | 68.16 |
| 2023-12-31 | $43k | 682 | 62.60 |
| 2023-09-30 | $31k | 682 | 45.39 |
| 2023-06-30 | $38k | 682 | 56.14 |
| 2023-03-31 | $35k | 772 | 45.23 |
| 2022-12-31 | $31k | 772 | 40.65 |
| 2022-09-30 | $50k | 772 | 64.77 |
| 2022-03-31 | $48k | 772 | 62.18 |
| 2021-12-31 | $32k | 428 | 74.77 |
| 2021-09-30 | $48k | 428 | 112.15 |
| 2021-06-30 | $69k | 428 | 161.22 |
| 2021-03-31 | $52k | 428 | 121.50 |
More positions owned by Twin Lakes Capital Management
View all positions for Twin Lakes Capital Management